Registrational

Companies like Athira Pharma (), with much smaller market caps, have drug candidates in potentially registrational trials, with apparently safer drugs, and have already reported efficacy of their drug candidates.

To that end, we believe the data from the ongoing batoclimab CIDP trial could substantially enhance the design of a potentially registrational study with IMVT-1402.

Aramchol is currently in a Phase registrational study for NASH and fibrosis (ARMOR) and has been granted Fast Track designation status by the FDA for the treatment of NASH.